-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DgBFI8E9s4+cgIaAmIhzDDJSfy9ORTeizJCaLuNbhmGWrLQ0AJk/pFSDMfQ1W5Ff kWVsHlPUkuL5WCRnB1bEXA== 0000912057-02-023981.txt : 20020612 0000912057-02-023981.hdr.sgml : 20020612 20020612163203 ACCESSION NUMBER: 0000912057-02-023981 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20020612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-86624 FILM NUMBER: 02677493 BUSINESS ADDRESS: STREET 1: 106 CHARLES LINDBERGH BLVD CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: 5162220023 MAIL ADDRESS: STREET 1: 106 CHARLES LINDBERGH BLVD CITY: UNIONDALE STATE: NY ZIP: 11553-3649 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 424B3 1 a2082225z424b3.htm FORM 424(B)(3)

Filed pursuant to Rule 424(b)(3) and (c)
Registration No. 333-86624

PROSPECTUS SUPPLEMENT NO. 4 DATED JUNE 12, 2002

$200,000,000

LOGO

4% Convertible Senior Subordinated Notes Due 2009
And 4,000,000 Shares Of Common Stock Issuable Upon
Conversion Of The Notes

        This Prospectus Supplement relates to resales by selling securityholders of our 4% Convertible Senior Subordinated Notes due 2009 and shares of our common stock into which the notes are convertible.

        This Prospectus Supplement should be read in conjunction with the Prospectus dated May 10, 2002, (the "Prospectus") which is to be delivered with this Prospectus Supplement.

        SEE "RISK FACTORS," BEGINNING ON PAGE 5 OF THE PROSPECTUS AS THEY MAY BE MODIFIED AND INCORPORATED BY REFERENCE, TO READ ABOUT FACTORS YOU SHOULD CONSIDER BEFORE BUYING THE NOTES OR OUR COMMON STOCK.

        NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATIONS TO THE CONTRARY IS A CRIMINAL OFFENSE.

The date of this Prospectus Supplement is June 12, 2002.


The date of this Prospectus Supplement is June 12, 2002.

        The information in the table appearing in the Prospectus under the heading "Selling Securityholders" is superseded by the information appearing in the following table:

Selling Securityholder*

  Principal
Amount of Notes
Beneficially Owned
and Offered(15)

  Common Stock
Issuable Upon
Conversion of
the Notes (1)

  Common Stock
Offered (1)

  Principal Amount
of the Notes
Owned After
Completion of
Offering

  Common Stock
Owned After
Completion of
Offering

Argent Classic Convertible Arbitage Fund (Bermuda) Ltd.   $ 1,500,000 (9) 30,000   30,000   0   0
Argent Low Lev Convertible Arbitage Fund Ltd.   $ 1,000,000 (9) 20,000   20,000   0   0
Aristeria International Limited   $ 10,640,000 (2) 212,800   212,800   0   0
Aristeria Partners, LP   $ 3,360,000 (2) 67,200   67,200   0   0
B.G.I. Global Investors
c/o Forest Investment Management L.L.C.
  $ 440,000 (13) 8,800   8,800   0   0
Calamos® Market Neutral Fund — Calamos® Investment Trust   $ 10,000,000 (3) 200,000   200,000   0   0
Consulting Group Capital Markets Fund   $ 530,000 (3) 10,600   10,600   0   0
Continental Assurance Company   $ 500,000 (8) 10,000   10,000   0   0
Continental Casualty Company   $ 3,000,000 (8) 60,000   60,000   0   0
CSFB Convertible & Quantative Strategies Ltd.   $ 500,000 (4) 10,000   10,000   0   0
Deutsche Bank Securities Inc.   $ 5,000,000 (7) 100,000   100,000   0   0
Fidelity Commonwealth Trust: Fidelity Mid-Cap Stock Fund   $ 10,510,000   210,200   210,200   0   0
Fidelity Financial Trust: Fidelity Convertible Securities Fund   $ 2,485,000   49,700   49,700   0   0
First Union Securities Inc.   $ 15,250,000   305,000   305,000   0   0
Forest Alternative Strategies II   $ 140,000 (13) 2,800   2,800   0   0
Forest Global Convertible Fund Series A-5   $ 7,210,000 (13) 144,200   144,200   0   0
Forest Fulcrum Fund L.L.P.   $ 1,780,000 (13) 35,600   35,600   0   0
Grace Brothers, Ltd.   $ 1,000,000   20,000   20,000   0   0
Grace Brothers Management L.L.C.   $ 2,300,000   46,000   46,000   0   0
JP Morgan Securities   $ 29,000,000 (11) 580,000   580,000   0   0
KBC Financial Products (Cayman Islands)   $ 7,000,000 (5) 140,000   140,000   0   0
KBC Financial Products, USA, Inc.   $ 4,000,000 (4) 80,000   80,000   0   0
Lincoln National Convertible Securities Fund   $ 2,550,000 (5) 51,000   51,000   0   0
LLT Limited   $ 500,000 (13) 10,000   10,000   0   0
Merrill Lynch Pierce Fenner & Smith Inc.   $ 6,690,000 (9) 133,800   133,800   0   0
MLQA Convertible Securities Arbitrage, LTD.   $ 15,000,000 (14) 300,000   300,000   0   0
Morgan Stanley & Co.   $ 7,000,000 (6) 140,000   140,000   0   0
Morgan Stanley Dean Witter Convertible Securities Trust   $ 1,000,000   20,000   20,000   0   0
Ramius Capital Group   $ 1,000,000   20,000   20,000   0   0
Ramius LP   $ 133,000 (12) 2,660   2,660   0   0
RCG Baldwin LP   $ 267,000 (12) 5,340   5,340   0   0
RCG Halifax Master Fund, LTD.   $ 750,000   15,000   15,000   0   0
RCG Latitude Master Fund, LTD.   $ 3,250,000   65,000   65,000   0   0
RCG Multi Strategy LP   $ 2,000,000   40,000   40,000   0   0
Relative Value International Holdings, LLC   $ 500,000 (10) 10,000   10,000   0   0
Robertson Stephens   $ 25,000,000 (7) 500,000   500,000   0   0
Tribeca Investments, L.L.C.   $ 9,300,000   186,000   186,000   0   0
UFJ Investments Asia Limited   $ 500,000   10,000   10,000   0   0
Wachovia Securities International Ltd.   $ 11,000,000   220,000   220,000   0   0
Whitebox Convertible Arbitrage Partners, L.P.   $ 5,000,000   100,000   100,000   0   0
Zurich Master Hedge Fund
c/o Forest Investment Management L.L.C.
  $ 530,000 (13) 10,600   10,600   0   0

*
Information about other selling securityholders will be set forth in prospectus supplements or amendments, if required.
(1)
Assumes conversion of all of the securityholders' notes at a conversion rate of 20 shares of common stock per $1,000 principal amount of the notes. This conversion rate is subject to adjustment, however, as described under "Description of the Notes—Conversion Rights." As a result, the number of shares of common stock issuable upon conversion of the notes may increase or decrease in the future.
(2)
Information provided as of February 20, 2002.

(3)
Information provided as of March 19, 2002.
(4)
Information provided as of May 8, 2002.
(5)
Information provided as of May 10, 2002.
(6)
Information provided as of April 24, 2002.
(7)
Information provided as of May 14, 2002.
(8)
Information provided as of May 15, 2002.
(9)
Information provided as of May 16, 2002.
(10)
Information provided as of May 22, 2002.
(11)
Information provided as of May 24, 2002.
(12)
Information provided as of June 4, 2002.
(13)
Information provided as of June 10, 2002.
(14)
Information provided as of June 11, 2002.
(15)
Amounts indicated may be in excess of the total amount registered due to sales or transfers exempt from the registration requirements of the Securities Act of 1933, as amended, since the date upon which the selling securityholders provided to us the information regarding their notes.


GRAPHIC 3 g216754.jpg G216754.JPG begin 644 g216754.jpg M_]C_X``02D9)1@`!`0$!KP&O``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#`6>2>GB M-@MW;JK3$OJKD.+"@O>%Z^)D$-((\T@Y41]`*C;E[0+-!46V5.2UCD>"!M'_ M`"/+[9JLZSU"_=+C^"6[<6$+#:DM]7G,XQZ`\O6K!:-(VJP6XSKJEIY]M!6Z MXX,H;'<)'[]36O\`301,$DP-NT:-?,_:EF\>61Q9$=-2=/),V/:?"4Z`];WT M()^)"TJ./3E5LM5\M]Z9+D&0ES'Q(/)2?4=141"N&F=4<2"W':64ISPW&=AQ MYI/U[51[U;9>B[^U(@O*#2LJ86>>1W0KS_<8KH86"=QB:TQOW`Z%WB-RV"JEKN\2K=;XT:$LMR);NP+3U2D=<>I(%3=BN[-[M+,UH;=PPM']"A MU%5OVBPWE0H-Q:;*Q#>RO'8'!SZ9`^]9,'&!BFLE&AW\?[6G$O)PYUR7FYT=2>*X5Y#@)P<@_,]*:7V\(N6EGD"OG MG/'N203G.%=B#FMT;WAC7S-)=9'\JK4=#HLCV-+BR,@-H=+O3S"XS9+;;=.WB M5:I;CT:3#7@%P+2"$GF#]:=^S_\`RC&_WN?]C5/M;:8L[4,:URE2+4F"Z5+S ME.=ON\^A.Y_V-<8QCFP.S.NW-.W70Z\UUAG!TK:%4#T MU&B93K9$NGM"<:EI44(MZ5I*5E!"MV,@@^1-1?C%I<=B*F*D085XC!EYU62$ M\R05=P,5+RK=#N?M$=8FL(>;%N2H)7V._K^=+ZFMD-BTVV`Q';9C+N+"2VA. M!@DYHR5H+&.LV!Y$5YQC=Z]\8I&X[6]:6M6W.(7?YU3%A62%I`-&M^EDCARZ*R2=[`03M M%_3GS5UN&J+;;);L62MP/-I0K8ELJ*MW0)QU/*DY>K+;$DR8RDR7'XYPMIID MJ5C;N)Y=@.III%:;7[1KBXI(*VX+6TGMDG/Z4G:6VSJ/53NT%>YM&?EP\XKC MP8@+(.QH.O&N7-=>)(3L(VDCTM//XRM!6QL6\MITH'&2T2VA2NB5*['Y4YG: MCAPICD0-29#[+?$>3':W\-/FK^W6JAPT-^RB&4@#+LP MV_!MJ(K:2ZZZT%.OY3D8YCEV[UV["QYCE!H$C7@0+TYZ!IK=4[',0A+S3R"E:2?A&.^ M>V.M4V&^+?:M'W)\8ALJ=0ZO&0V59`)J6U>S"?L[DZ"AEY:7V7I*F%`J6VDG MJ1SY4.%C:\,-[21?1U5Z=P@Q#RTN%;!IY7W4^Q?XCS[C"VY##Z&N-PWVBA2D M#J1YT+U!!184WDESPBDI4#L][!.!R]:CH\*Q/M&;;W>/(7'<2T52E.*PHM>/XNMN\D"08P>X!E!H\'?G&-WKRSC%-K%.M%UL-M#GAUO1DH`97C$B#%8=D)2W;V6AO&'!DJ.>1Y9.!^M2S"L=(692*-=^7 M#R4.Q#FLS6#LOMS_`.JQJD-1==SY#ZPAIJUI6M1[`+.:DH>HHTQP(3%G-I4C MB(6['4E*T\N8/U%0\X1%ZQNB)ZTHBKM24NJ4K`"2LCKVIE'NZ[J;2-VO]Z\2)$9$5*4 MH;2I2MR4_P"HXQU)S^56]V,Y'M*XUO"&UH9*&-QPE)Q@9IY1663$R2-:QVC= M%H9`QCG.&I5$TOHB7:;TF=/=CNAM!X8;42=YY9.0.V?O5JOL,S[%-BISN=94 ME.//'+\ZD:*F;%22R"5YVCZ*(\.R-AC;H5B>D)?@]50'%<;!&$-@YV]/0?6K7K:^*L]D M*8[I;F2%;&BGJD=5*^@_6LTF#ECG;%FMQ^2N9B8WQ.DKW1\U/MPXS3"F&X[2 M&5$GWN>>?+GSIW10.(T*$`ZI-+#27E M/!M`=4`E2PD;B!T!-<3'90MQ:6D)4[\9"0"KU\Z5HI92@D/!QO#"/X=K@)Z- M[!M'//3I7'8,1Y]+SL9E;J?A6IL%0]#3BBF8\4H)$1(XC>&##08QCA[!MQZ= M*\1;?#A)6F+$88"_B#383N]<=:8AQVG3U6AI*5'Z M@5Y3:X"5.J3"C`O?XA#2??YYY\N?.GE%3G=Q496\$A*A1IK0:E1V7VQSVNH" MA^==:BQV5;FF&T*VA&4H`.T=!Z#RI:BHS&JM30NTS_"H'BQ*\%&\0#D.\).[ M/GG&:[^&0=RU>#C[G/C/"3E7///ESY\Z=T5.=W%1E;P2*XD=U:UN,-*4M.Q1 M4@$J3Y'S'RKQ%M\.%N\+%88W=>$V$Y^U.:*C,:JU.47:****A2BBBBB*$U/I M]K4%L+)(1(;.YAP]E>1^1[UGUCOL_1MP<@7&,YX=2LK:[I/]2#T/[UKE-9L" M)<&PS,C-/M^3B0<>GE6[#8P1QF&5N9A^719)L,7O$D9IP595K#2@=$[`,K'Q M"*>)]\?O58O>I;AJY]-LM<5T1R@`\JN7\%:>XX_P#6IQY<1>/M MFI-4&+;X"F83"(Z.0PT-IZCN.=7LQ.%A<'Q-)=NS50]%4Z&>0%KW`#?6]5VW M-6[0=H*ICR7+A(P2A'-;A[)2/(>=,HFG+CJJ[?BU^;5'BC_"BD^\4]D_(>?< M_*KC$L]OB/>(9BHXZ^:GEY6L_P#)634A5!QI:7/9\9U
-----END PRIVACY-ENHANCED MESSAGE-----